Market Cap 11.30B
Revenue (ttm) 570.40M
Net Income (ttm) 223.19M
EPS (ttm) N/A
PE Ratio 50.99
Forward PE 50.44
Profit Margin 39.13%
Debt to Equity Ratio 0.00
Volume 491,796
Avg Vol 2,537,570
Day's Range N/A - N/A
Shares Out 187.83M
Stochastic %K 86%
Beta 1.32
Analysts Sell
Price Target $61.22

Company Profile

Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants...

Industry: Health Information Services
Sector: Healthcare
Phone: 650 549 4330
Address:
500 3rd Street, Suite 510, San Francisco, United States
ZacksResearch
ZacksResearch Jun. 26 at 1:59 PM
$DOCS is redefining healthcare tech! 🚀 🔍 From a physician network to a broader healthcare tech platform, Doximity's enterprise tools are now central to its growth story, with AI usage among unique prescribers growing more than fivefold YoY. 📈 Despite a 12.7% YTD gain, its forward 12-month P/S of 17.8X raises valuation concerns against an industry average of 6X. Discover how Doximity's transformation could impact its market position 👉 https://www.zacks.com/commentary/2554330/does-docs-shift-toward-enterprise-offerings-signal-a-long-term-pivot?cid=sm-stocktwits-2-2554330-body-178&ADID=SYND_STOCKTWITS_TWEET_2_2554330_BODY_178
0 · Reply
ZacksResearch
ZacksResearch Jun. 26 at 12:52 PM
Is $DOCS finally evolving past its pharma roots? The company is leaning harder into enterprise with AI and workflow tools — a shift that could reshape its long-term identity. See what this pivot means for investors 👉 https://www.zacks.com/stock/news/2554330/does-docs-shift-toward-enterprise-offerings-signal-a-long-term-pivot?cid=sm-stocktwits-2-2554330-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2554330_TEASER
0 · Reply
WOLFSTREET
WOLFSTREET Jun. 26 at 12:59 AM
$DOCS $61 WOWZER!, thats a long way since getting $43 in pre market. How proud am I of CC?, you have no idea. I do not have to draw subjective lines like so many do, they do love lines all over the bars, dont they? No need for crayolas. I do not watch the media, I outright ignore analysts. Oh, ANALYSTS, they outright suck!, retail investors are sometimes misled by analysts everyday, particularly regarding stock recommendations and price targets. Happens when analysts issue overly optimistic ratings to generate trading volume or when consensus target prices are inflated. This leads poor fools to underestimate the true risk and potential losses. Here is where CC steps in, no work, no lies, no BS, no lines, no nonsense. YOU KNOW, WHEN YOU KNOW, and YOU KNOW, WHEN YOU KNOW CC 🥂
0 · Reply
CarloNoS
CarloNoS Jun. 25 at 6:30 PM
$DOCS getting ready to launch?
0 · Reply
NeverFadeTheOracle
NeverFadeTheOracle Jun. 24 at 4:49 PM
$TDOC $DOCS Sec Kennedy “ Access to quality healthcare…We’re expanding rural health care access…, every corner of the country.”
0 · Reply
InvestorWisdom
InvestorWisdom Jun. 24 at 2:18 PM
$DOCS chart looking interesting. Launch pad… watching for volume
0 · Reply
honestinvt7672
honestinvt7672 Jun. 21 at 6:15 AM
$DOCS Avg $25 holding till I'm 70 15 yrs to go
0 · Reply
rvgilliam
rvgilliam Jun. 20 at 2:38 PM
$DOCS Like the move off the 50 day on 6/17... good volume
0 · Reply
swingingtech
swingingtech Jun. 20 at 1:39 PM
$DOCS https://wallstreetwaves.com/can-ai-tools-propel-docs-into-the-future-of-growth/
0 · Reply
ZacksResearch
ZacksResearch Jun. 20 at 1:28 PM
AI is driving $DOCS forward, but is it enough to boost short-term revenues? 🤔 Doximity's AI tools, like Doximity GPT, are enhancing engagement and clinician workflow. Management hasn't quantified the revenue impact, indicating a long-term play rather than immediate growth. Full analysis here 👉 https://www.zacks.com/commentary/2519589/will-ai-tools-like-docsgpt-drive-the-next-leg-of-growth-for-docs?cid=sm-stocktwits-2-2519589-body&ADID=SYND_STOCKTWITS_TWEET_2_2519589_BODY
0 · Reply
Latest News on DOCS
Doximity Stock 7.8% Higher After Key Trading Signal

May 19, 2025, 7:47 AM EDT - 5 weeks ago

Doximity Stock 7.8% Higher After Key Trading Signal


These Analysts Cut Their Forecasts On Doximity After Q4 Results

May 16, 2025, 1:51 PM EDT - 5 weeks ago

These Analysts Cut Their Forecasts On Doximity After Q4 Results


Doximity, Inc. (DOCS) Q4 2025 Earnings Call Transcript

May 15, 2025, 8:35 PM EDT - 6 weeks ago

Doximity, Inc. (DOCS) Q4 2025 Earnings Call Transcript


Doximity Stock Drops 20% After Outlook Disappoints

May 15, 2025, 5:55 PM EDT - 6 weeks ago

Doximity Stock Drops 20% After Outlook Disappoints


Doximity: Rating Downgrade As Near-Term Upside Is Priced In

Feb 14, 2025, 5:53 PM EST - 4 months ago

Doximity: Rating Downgrade As Near-Term Upside Is Priced In


Doximity Momentum, Big Money Support Stays Strong

Feb 14, 2025, 7:49 AM EST - 4 months ago

Doximity Momentum, Big Money Support Stays Strong


Doximity Q3 Earnings: Outpacing Even Management's Expectations

Feb 10, 2025, 12:04 PM EST - 4 months ago

Doximity Q3 Earnings: Outpacing Even Management's Expectations


Doximity shares pop 30% on revenue beat, rosy guidance

Feb 7, 2025, 10:38 AM EST - 5 months ago

Doximity shares pop 30% on revenue beat, rosy guidance


Doximity, Inc. (DOCS) Q3 2025 Earnings Call Transcript

Feb 6, 2025, 8:01 PM EST - 5 months ago

Doximity, Inc. (DOCS) Q3 2025 Earnings Call Transcript


Doximity Announces Fiscal 2025 Third Quarter Financial Results

Feb 6, 2025, 4:01 PM EST - 5 months ago

Doximity Announces Fiscal 2025 Third Quarter Financial Results


Doximity Q2 Earnings: Positioning Is Paying Off

Nov 15, 2024, 8:00 AM EST - 8 months ago

Doximity Q2 Earnings: Positioning Is Paying Off


Doximity, Inc. (DOCS) Q2 2025 Earnings Call Transcript

Nov 7, 2024, 10:07 PM EST - 8 months ago

Doximity, Inc. (DOCS) Q2 2025 Earnings Call Transcript


Doximity Announces Fiscal 2025 Second Quarter Financial Results

Nov 7, 2024, 4:01 PM EST - 8 months ago

Doximity Announces Fiscal 2025 Second Quarter Financial Results


Overlooked Stock: DOCS

Oct 15, 2024, 4:50 PM EDT - 9 months ago

Overlooked Stock: DOCS


Top 4 Health Care Stocks That May Keep You Up At Night

Sep 24, 2024, 8:51 AM EDT - 9 months ago

Top 4 Health Care Stocks That May Keep You Up At Night

BFRG GILD GNFT


Doximity Stock Jumps 31%. Here's Why.

Aug 9, 2024, 9:38 AM EDT - 11 months ago

Doximity Stock Jumps 31%. Here's Why.


Doximity, Inc. (DOCS) Q1 2025 Earnings Call Transcript

Aug 8, 2024, 8:46 PM EDT - 11 months ago

Doximity, Inc. (DOCS) Q1 2025 Earnings Call Transcript


Doximity Announces Fiscal 2025 First Quarter Financial Results

Aug 8, 2024, 4:01 PM EDT - 11 months ago

Doximity Announces Fiscal 2025 First Quarter Financial Results


ZacksResearch
ZacksResearch Jun. 26 at 1:59 PM
$DOCS is redefining healthcare tech! 🚀 🔍 From a physician network to a broader healthcare tech platform, Doximity's enterprise tools are now central to its growth story, with AI usage among unique prescribers growing more than fivefold YoY. 📈 Despite a 12.7% YTD gain, its forward 12-month P/S of 17.8X raises valuation concerns against an industry average of 6X. Discover how Doximity's transformation could impact its market position 👉 https://www.zacks.com/commentary/2554330/does-docs-shift-toward-enterprise-offerings-signal-a-long-term-pivot?cid=sm-stocktwits-2-2554330-body-178&ADID=SYND_STOCKTWITS_TWEET_2_2554330_BODY_178
0 · Reply
ZacksResearch
ZacksResearch Jun. 26 at 12:52 PM
Is $DOCS finally evolving past its pharma roots? The company is leaning harder into enterprise with AI and workflow tools — a shift that could reshape its long-term identity. See what this pivot means for investors 👉 https://www.zacks.com/stock/news/2554330/does-docs-shift-toward-enterprise-offerings-signal-a-long-term-pivot?cid=sm-stocktwits-2-2554330-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2554330_TEASER
0 · Reply
WOLFSTREET
WOLFSTREET Jun. 26 at 12:59 AM
$DOCS $61 WOWZER!, thats a long way since getting $43 in pre market. How proud am I of CC?, you have no idea. I do not have to draw subjective lines like so many do, they do love lines all over the bars, dont they? No need for crayolas. I do not watch the media, I outright ignore analysts. Oh, ANALYSTS, they outright suck!, retail investors are sometimes misled by analysts everyday, particularly regarding stock recommendations and price targets. Happens when analysts issue overly optimistic ratings to generate trading volume or when consensus target prices are inflated. This leads poor fools to underestimate the true risk and potential losses. Here is where CC steps in, no work, no lies, no BS, no lines, no nonsense. YOU KNOW, WHEN YOU KNOW, and YOU KNOW, WHEN YOU KNOW CC 🥂
0 · Reply
CarloNoS
CarloNoS Jun. 25 at 6:30 PM
$DOCS getting ready to launch?
0 · Reply
NeverFadeTheOracle
NeverFadeTheOracle Jun. 24 at 4:49 PM
$TDOC $DOCS Sec Kennedy “ Access to quality healthcare…We’re expanding rural health care access…, every corner of the country.”
0 · Reply
InvestorWisdom
InvestorWisdom Jun. 24 at 2:18 PM
$DOCS chart looking interesting. Launch pad… watching for volume
0 · Reply
honestinvt7672
honestinvt7672 Jun. 21 at 6:15 AM
$DOCS Avg $25 holding till I'm 70 15 yrs to go
0 · Reply
rvgilliam
rvgilliam Jun. 20 at 2:38 PM
$DOCS Like the move off the 50 day on 6/17... good volume
0 · Reply
swingingtech
swingingtech Jun. 20 at 1:39 PM
$DOCS https://wallstreetwaves.com/can-ai-tools-propel-docs-into-the-future-of-growth/
0 · Reply
ZacksResearch
ZacksResearch Jun. 20 at 1:28 PM
AI is driving $DOCS forward, but is it enough to boost short-term revenues? 🤔 Doximity's AI tools, like Doximity GPT, are enhancing engagement and clinician workflow. Management hasn't quantified the revenue impact, indicating a long-term play rather than immediate growth. Full analysis here 👉 https://www.zacks.com/commentary/2519589/will-ai-tools-like-docsgpt-drive-the-next-leg-of-growth-for-docs?cid=sm-stocktwits-2-2519589-body&ADID=SYND_STOCKTWITS_TWEET_2_2519589_BODY
0 · Reply
ZacksResearch
ZacksResearch Jun. 20 at 12:20 PM
Will $DOCS' AI push actually move the needle? DOCS is betting on tools like Doximity GPT to drive growth after a strong FY25, but monetization is still in early innings. See what could make or break the AI thesis 👉 https://www.zacks.com/stock/news/2519589/will-ai-tools-like-docsgpt-drive-the-next-leg-of-growth-for-docs?cid=sm-stocktwits-2-2519589-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2519589_TEASER
0 · Reply
vu_jade
vu_jade Jun. 17 at 4:35 PM
$DOCS breaking out
0 · Reply
LiveTradePro
LiveTradePro Jun. 17 at 4:17 PM
$DOCS Strong move https://share.trendspider.com/chart/DOCS/66820q7v61
0 · Reply
ARMRreport
ARMRreport Jun. 17 at 2:05 PM
$DOCS lovin it 3 min chart
0 · Reply
ARMRreport
ARMRreport Jun. 17 at 2:00 PM
$DOCS important to monitor TRUMP ADMINISTRATION SAID TO CONSIDER CRACKDOWN ON PHARMA ADS #StocksToWatch #StocksToBuy
1 · Reply
RunnerSignals
RunnerSignals Jun. 15 at 2:10 PM
Short Squeeze Radar $DT and $BTI are showing bullish momentum with rising interest! $PWR $DOCS $NI also worth watching as short interest shifts https://stocksrunner.com/news/2025-06-15-high-short-interest-stocks-to-watch-now-and-which-could-trigger-a-squeeze-or-a-slide
0 · Reply
WOLFSTREET
WOLFSTREET Jun. 11 at 9:30 PM
$DOCS I use CC, I have CC data, it is comprehensive, it is quantitative. I do not day trade, CC is not designed to day trade. On my street, most know, I have no need to watch any CC data driven trade on a day by day, actually,, sometimes I'm not even looking at this for months. Right now SETUP#1 was taken out before I joined this party. I am using SETUP#2 for next leg up. Data guides, it how I trade. I absolutely ignore the market roller coaster on every ticker.
1 · Reply
ZacksResearch
ZacksResearch Jun. 11 at 5:34 PM
Is $DOCS a hidden gem or overvalued at 39.4x P/E? 🤔 Shares are up 9.6% YTD, outperforming the industry, but valuation remains high compared to peers. The Zacks Consensus Estimate for fiscal 2026 suggests modest EPS growth of 3.5%. Discover if DOCS has more room to run here 👉 https://www.zacks.com/commentary/2494487/docs-boosts-client-retention-via-workflow-integration-and-ai-tools?cid=sm-stocktwits-2-2494487-body&ADID=SYND_STOCKTWITS_TWEET_2_2494487_BODY
0 · Reply
ZacksResearch
ZacksResearch Jun. 11 at 4:13 PM
$DOCS doubling down on stickiness with AI integration 🧠📈 Embedding clinical workflows + AI tools = deeper client retention and platform loyalty. Find out what’s driving the loyalty surge 👉 https://www.zacks.com/stock/news/2494487/docs-boosts-client-retention-via-workflow-integration-and-ai-tools?cid=sm-stocktwits-2-2494487-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2494487_TEASER
0 · Reply
WOLFSTREET
WOLFSTREET Jun. 10 at 7:42 PM
$DOCS ...and here was the exact post in real-time I boarded the CC ship, raised the flag, and went sailing into unfriendly waters to scoop this one up!
1 · Reply
WOLFSTREET
WOLFSTREET Jun. 10 at 7:40 PM
$DOCS remember last earnings? all I did was look at CC data and had all the data I needed. Like a kid i a candy store in the pre/post-market. Reason I saved this screen shot for ya.
0 · Reply
WOLFSTREET
WOLFSTREET Jun. 10 at 6:52 PM
$DOCS Yet up nearly 30% in just 1 MONTH! $15 PT was the wrong wayyyyyyyyyyyyyyyy Recommendation here: Do opposite
0 · Reply